Surgery Partners PE Ratio 2013-2024 | SGRY

Current and historical p/e ratio for Surgery Partners (SGRY) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Surgery Partners PE ratio as of November 20, 2024 is 32.97.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Surgery Partners PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-11-19 22.75 0.00
2024-09-30 32.24 $-0.23 0.00
2024-06-30 23.79 $-0.27 0.00
2024-03-31 29.83 $-0.00 0.00
2023-12-31 31.99 $-0.10 0.00
2023-09-30 29.25 $-0.32 0.00
2023-06-30 44.99 $-0.56 0.00
2023-03-31 34.47 $-0.92 0.00
2022-12-31 27.86 $-0.58 0.00
2022-09-30 23.40 $-0.35 0.00
2022-06-30 28.92 $-0.35 0.00
2022-03-31 55.05 $-0.53 0.00
2021-12-31 53.41 $-1.24 0.00
2021-09-30 42.34 $-1.34 0.00
2021-06-30 66.62 $-2.52 0.00
2021-03-31 44.26 $-2.99 0.00
2020-12-31 29.01 $-3.18 0.00
2020-09-30 21.90 $-3.65 0.00
2020-06-30 11.57 $-2.70 0.00
2020-03-31 6.53 $-2.43 0.00
2019-12-31 15.66 $-2.27 0.00
2019-09-30 7.39 $-4.95 0.00
2019-06-30 8.14 $-5.05 0.00
2019-03-31 11.28 $-5.03 0.00
2018-12-31 9.79 $-4.96 0.00
2018-09-30 16.50 $-2.54 0.00
2018-06-30 14.90 $-2.59 0.00
2018-03-31 17.15 $-2.11 0.00
2017-12-31 12.10 $-1.64 0.00
2017-09-30 10.35 $-0.46 0.00
2017-06-30 22.75 $0.15 151.67
2017-03-31 19.50 $0.28 69.64
2016-12-31 15.85 $0.19 83.42
2016-09-30 20.24 $0.19 106.53
Sector Industry Market Cap Revenue
Medical Medical Services $2.892B $2.743B
Surgery Partners, Inc. is a healthcare services company. The Company's outpatient delivery model focused on providing solutions for surgical and related ancillary care in support of its patients and physicians. Its operating segment consists of Surgical Facility Services segment, Ancillary Services segment and Optical Services segment. Surgery Partners, Inc. is based in Nashville, Tennessee.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00